CL2010000554A1 - Proceso de preparacion de 2-[4-(4-fluoro-2-metil-1h-indol-5-iloxi)-5-metilpirrolo[2,1-f][1,2,4]triazin-6-iloxi]-1-metiletilico del acido [(1r),2s]-2-aminopropionico (div. sol. 1141-07). - Google Patents

Proceso de preparacion de 2-[4-(4-fluoro-2-metil-1h-indol-5-iloxi)-5-metilpirrolo[2,1-f][1,2,4]triazin-6-iloxi]-1-metiletilico del acido [(1r),2s]-2-aminopropionico (div. sol. 1141-07).

Info

Publication number
CL2010000554A1
CL2010000554A1 CL2010000554A CL2010000554A CL2010000554A1 CL 2010000554 A1 CL2010000554 A1 CL 2010000554A1 CL 2010000554 A CL2010000554 A CL 2010000554A CL 2010000554 A CL2010000554 A CL 2010000554A CL 2010000554 A1 CL2010000554 A1 CL 2010000554A1
Authority
CL
Chile
Prior art keywords
yloxy
methyl
indole
fluoro
methylpyrrolo
Prior art date
Application number
CL2010000554A
Other languages
English (en)
Inventor
Gerard A Crispino
Mourad Hamedi
Thomas L Laporte
John E Thornton
Zhongmin Xu
Paul C Lobben
Jean A Pesti
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38357966&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2010000554(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of CL2010000554A1 publication Critical patent/CL2010000554A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Proceso para la preparación del ester 2-[4-(4-fluoro-2-metil-1h-indol-5-iloxi)-5-metilpirrolo[2,1-f][1,2,4]triazin-6-iloxi]-1-metiletilico del ácido[(1r), 2-s]-2-aminopropionico, a partir de 6-(etoximetil)-5-metoxipirrolo[2,1-f][1,2,4]triazin-4(3h)-ona y de 4-fluoro-2-metil-1h-indol-5-ol (divisional Sol. 1141-2007).
CL2010000554A 2006-04-21 2010-05-28 Proceso de preparacion de 2-[4-(4-fluoro-2-metil-1h-indol-5-iloxi)-5-metilpirrolo[2,1-f][1,2,4]triazin-6-iloxi]-1-metiletilico del acido [(1r),2s]-2-aminopropionico (div. sol. 1141-07). CL2010000554A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74530006P 2006-04-21 2006-04-21

Publications (1)

Publication Number Publication Date
CL2010000554A1 true CL2010000554A1 (es) 2010-10-15

Family

ID=38357966

Family Applications (2)

Application Number Title Priority Date Filing Date
CL2007001141A CL2007001141A1 (es) 2006-04-21 2007-04-20 Proceso para la preparacion de 5-metilpirrolo[2,1-f][1,2,4]triazin-6-ol en forma continua.
CL2010000554A CL2010000554A1 (es) 2006-04-21 2010-05-28 Proceso de preparacion de 2-[4-(4-fluoro-2-metil-1h-indol-5-iloxi)-5-metilpirrolo[2,1-f][1,2,4]triazin-6-iloxi]-1-metiletilico del acido [(1r),2s]-2-aminopropionico (div. sol. 1141-07).

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CL2007001141A CL2007001141A1 (es) 2006-04-21 2007-04-20 Proceso para la preparacion de 5-metilpirrolo[2,1-f][1,2,4]triazin-6-ol en forma continua.

Country Status (23)

Country Link
US (1) US7671199B2 (es)
EP (1) EP2010538B1 (es)
JP (1) JP5203353B2 (es)
KR (1) KR101423789B1 (es)
CN (1) CN101472927B (es)
AR (1) AR060622A1 (es)
AU (1) AU2007240453B2 (es)
BR (1) BRPI0710691A2 (es)
CA (1) CA2650059A1 (es)
CL (2) CL2007001141A1 (es)
DK (1) DK2010538T3 (es)
EA (1) EA019693B1 (es)
ES (1) ES2399379T3 (es)
HR (1) HRP20130099T1 (es)
IL (1) IL194715A (es)
MX (1) MX2008013232A (es)
NO (1) NO20084326L (es)
PE (1) PE20080193A1 (es)
PL (1) PL2010538T3 (es)
PT (1) PT2010538E (es)
SI (1) SI2010538T1 (es)
TW (1) TWI378100B (es)
WO (1) WO2007124332A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007038648A1 (en) * 2005-09-27 2007-04-05 Bristol-Myers Squibb Company Crystalline forms of [(1r), 2s]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester
US20120135875A1 (en) * 2008-02-29 2012-05-31 Bristol-Myers Squibb Company Methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators
EP2376491B1 (en) 2008-12-19 2015-03-04 Cephalon, Inc. Pyrrolotriazines as alk and jak2 inhibitors
US11860139B2 (en) 2018-10-08 2024-01-02 Applied Photophysics Limited System and method for analysing the composition of a quenched flow reaction liquid

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6982265B1 (en) * 1999-05-21 2006-01-03 Bristol Myers Squibb Company Pyrrolotriazine inhibitors of kinases
TWI329112B (en) * 2002-07-19 2010-08-21 Bristol Myers Squibb Co Novel inhibitors of kinases
TWI272271B (en) * 2002-07-19 2007-02-01 Bristol Myers Squibb Co Process for preparing certain pyrrolotriazine compounds
US7432373B2 (en) * 2004-06-28 2008-10-07 Bristol-Meyers Squibb Company Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors
US7173031B2 (en) * 2004-06-28 2007-02-06 Bristol-Myers Squibb Company Pyrrolotriazine kinase inhibitors
WO2006130657A2 (en) * 2005-05-31 2006-12-07 Bristol-Myers Squibb Company Stereoselective reduction process for the preparation of pyrrolotriazine compounds
WO2007038648A1 (en) * 2005-09-27 2007-04-05 Bristol-Myers Squibb Company Crystalline forms of [(1r), 2s]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester

Also Published As

Publication number Publication date
HRP20130099T1 (hr) 2013-03-31
IL194715A (en) 2013-10-31
AU2007240453A1 (en) 2007-11-01
ES2399379T3 (es) 2013-04-01
CN101472927A (zh) 2009-07-01
MX2008013232A (es) 2008-10-21
AR060622A1 (es) 2008-07-02
JP5203353B2 (ja) 2013-06-05
US20070249610A1 (en) 2007-10-25
JP2009534413A (ja) 2009-09-24
KR20090008246A (ko) 2009-01-21
EA019693B1 (ru) 2014-05-30
CN101472927B (zh) 2012-07-04
US7671199B2 (en) 2010-03-02
CA2650059A1 (en) 2007-11-01
DK2010538T3 (da) 2013-03-18
TW200808799A (en) 2008-02-16
BRPI0710691A2 (pt) 2011-08-23
NO20084326L (no) 2008-11-18
PT2010538E (pt) 2013-02-22
EP2010538B1 (en) 2012-12-05
PE20080193A1 (es) 2008-03-10
EP2010538A1 (en) 2009-01-07
WO2007124332A1 (en) 2007-11-01
TWI378100B (en) 2012-12-01
CL2007001141A1 (es) 2008-01-18
SI2010538T1 (sl) 2013-06-28
PL2010538T3 (pl) 2013-04-30
KR101423789B1 (ko) 2014-07-30
AU2007240453B2 (en) 2012-04-12
EA200802171A1 (ru) 2009-08-28

Similar Documents

Publication Publication Date Title
IS2885B (is) Aðferð til að framleiða ljósfræðilega hrein virk efnasambönd
MX2009006865A (es) Proceso para la preparacion de compuestos 6,6-dimetil-3-aza-bicicl o-[3.1.0]-hexano utilizando intermediario bisulfitico.
AR066773A1 (es) Proceso para preparar alcoxidos de metales alcalinos
FR2884818B1 (fr) Procede de preparation d'acide acrylique a partir de glycerol
NZ592850A (en) Granulate of gamma-hydroxybutyric acid
AR062504A1 (es) Procedimientos para preparar acidos d,l-2hidroxi-4-alquiltiobutiricos
UA102518C2 (ru) Способ синтеза ивабрадина и его аддитивных солей с фармацевтически приемлемой кислотой
CL2012000560A1 (es) Procedimiento de preparacion del compuesto intermediario acido 3-oxo-tetrahidrotiofeno-2-carboxilico, utiles en la preparacion de dihidrotienopirimidinas (divisional de la solicitud 3095-08).
CL2010000554A1 (es) Proceso de preparacion de 2-[4-(4-fluoro-2-metil-1h-indol-5-iloxi)-5-metilpirrolo[2,1-f][1,2,4]triazin-6-iloxi]-1-metiletilico del acido [(1r),2s]-2-aminopropionico (div. sol. 1141-07).
AR063747A1 (es) Definilazetidinona sustituida con acido piperazina-1-sulfonico y que tiene propiedades farmacologicas mejoradas
ATE425961T1 (de) Salze substituierter allophansaureester und deren verwendung in arzneimitteln
MY151183A (en) Processes for the preparation of 4-oxo-octahydro-indole-1-carbocyclic acid methyl ester and derivatives thereof
AR060189A1 (es) Sales de malato y polimorfos de acido (3s, 5s)-7-[3-amino-5-metil-piperidinil]-1-ciclopropil-1,4-dihidro-8-metoxi-4-oxo-3-quinolincarboxilico
AR081514A1 (es) El compuesto 4-[etil(dimetil)amonio]butanoato, el metodo para la preparacion del mismo y el uso en el tratamiento de la enfermedad cardiovascular
WO2010022201A3 (en) Folinic acid derivatives for promoting bone growth
UY33459A (es) Purificación de productos anfóteros, o de productos propensos a ser convertidos en productos anfóteros
ATE466003T1 (de) Herstellung von 2-aminothiazol-5- carbonsäurederivaten
UY31282A1 (es) Intermediarios y métodos de preparacion de ésteres de derivados sustituidos del acido carboxilico 4-(2-oxo-1,2,4,5-tetrahidro-1,3-benzoldiazepina-3yl)-piperidina-1, sales farmacéuticamente aceptadas, isomeros,
CL2008002414A1 (es) Compuestos derivados de tetrahidronaftalenos sustituidos, composicion farmaceutica que comprende dichos compuestos, proceso de preparacion de dicha composicion y uso de los compuestos para tratar y/o prevenir trastornos del metabolismo de acidos grasos y trastornos de la utilizacion de la glucosa.
WO2006108717A3 (en) New method for the preparation of 6-(3-(1-adamantyl)-4-methoxphenyl)-2-naphthoic acid
EA200900897A1 (ru) Способ производства 6-[3-(1-адамантил)-4-метоксифенил]-2-нафтойной кислоты
NO20081264L (no) Krystallinske former av {(1R),2S]-2-Aminopropionsyre 2-[4-(4-Fluor-2-Metyl-1H-Indol-5-Yloksy)-5-Metylpyrrolo[2,1-F][1,2,4]Triazin-6-Yloksy]-1-Metyletylester
DE602005024679D1 (de) Verfahren zur herstellung von iminostilbenderivaten
BRPI0418664A (pt) método para produzir um derivado de ácido (met) acrìlico
WO2008111563A1 (ja) 鉄サラン錯体触媒を用いた光学活性スルホキシド化合物の製造法